| Symbol | ADPT |
|---|---|
| Name | ADAPTIVE BIOTECHNOLOGIES CORP |
| Sector | UNDEFINED |
| Region | UNDEFINED |
| Industry | Biological Products, (No Diagnostic Substances) |
| Address | 1165 EASTLAKE AVE E, SEATTLE, WA 98109 |
| Telephone | 206-659-0067 |
| Fax | — |
| — | |
| Website | — |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | — |
| Description | None |
RUBINSTEIN JULIE 🟡 adjusted position in 69.1K shares (4 derivative) of Adaptive Biotechnologies Corp (ADPT) at $14.66 ($2.0M) Transaction Date: Apr 17, 2026 | Filing ID: 000028
Read moreAdaptive Biotechnologies to Report First Quarter 2026 Financial Results on May 5, 2026
Read moreRUBINSTEIN JULIE 🟡 adjusted position in 57.2K shares (4 derivative) of Adaptive Biotechnologies Corp (ADPT) at $14.44 ($1.4M) Transaction Date: Apr 09, 2026 | Filing ID: 000024
Read moreLO FRANCIS 🟡 adjusted position in 22.6K shares (1 derivative) of Adaptive Biotechnologies Corp (ADPT) at $15.07 Transaction Date: Apr 08, 2026 | Filing ID: 000013
Read moreROBINS HARLAN S 🔴 sold 10.0K shares of Adaptive Biotechnologies Corp (ADPT) at $14.85 Transaction Date: Apr 08, 2026 | Filing ID: 000011
Read moreDirector ROBINS CHAD M 🔴 sold 120.6K shares of Adaptive Biotechnologies Corp (ADPT) at $15.19 ($1.8M) Transaction Date: Apr 06, 2026 | Filing ID: 000011
Read moreRUBINSTEIN JULIE 🟡 adjusted position in 69.1K shares (4 derivative) of Adaptive Biotechnologies Corp (ADPT) at $15.48 ($1.9M) Transaction Date: Apr 06, 2026 | Filing ID: 000022
Read more📋 Harlan Robins (Officer) plans to sell 10K shares of Adaptive Biotechnologies Corporation (at $14.84 each, total $148K) Filed: Apr 08, 2026 | ID: 000200
Read more📋 Chad Robins (Officer) plans to sell 37K shares of Adaptive Biotechnologies Corporation (at $14.84 each, total $553K) Filed: Apr 08, 2026 | ID: 000199
Read more📋 FRANCIS LO (Officer) plans to sell 23K shares of ADAPTIVE BIOTECHNOLOGIES CORPORATION (at $13.71 each, total $309K) Filed: Apr 08, 2026 | ID: 003321
Read more